0M4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mersana Therapeutics Inc

Watchlist Manager

Watchlist

Price: 6.8 EUR Market Closed

Market Cap: €1.2B

M	Mersana Therapeutics Inc SWB:0M4	US
	Saga Communications Inc NASDAQ:SGA	US
	Shofu Inc F:69W	JP
S	SeaWorld Entertainment Inc F:W2L	US

Profitability Summary

Mersana Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-203%

Negative 3Y Average Operating Margin

-330%

Operating Margin is Increasing

-568% > -203%

Negative Net Margin

-211%

Negative 3Y Average Net Margin

-323%

Net Margin is Increasing

-556% > -211%

Negative Free Cash Flow Margin

-224%

Negative 3Y Average Free Cash Flow Margin

-323%

Free Cash Flow Margin is Increasing

-232% > -224%

Exceptional ROE

240%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1.132%

ROIC is Increasing

-1.652% > -830%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-203%

Negative 3Y Average Operating Margin

-330%

Operating Margin is Increasing

-568% > -203%

Negative Net Margin

-211%

Negative 3Y Average Net Margin

-323%